Loxo Oncology Priced, Nasdaq: LOXO
Early-stage biotech developing targeted therapies to treat solid tumors.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
Early-stage biotech developing targeted therapies to treat solid tumors.
| IPO Data | |
|---|---|
| IPO File Date | 06/30/2014 |
| Offer Price | $13.00 |
| Price Range $12.00 - $14.00 | |
| Offer Shares (mm) | 5.3 |
| Deal Size ($mm) | $68 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 07/31/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $68 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Stamford, CT, United States |
| Founded | 2013 |
| Employees at IPO | 9 |
| Website www.loxooncology.com | |
IPO News for Loxo Oncology
Loxo Oncology (LOXO) Performance
